Munich
Germany
Technische Universität München (TUM) - Department of Neurology
multiple sclerosis, Central-Eastern Europe, multicentric, quality of care, disease modifying therapy, epidemiology
Multiple sclerosis (MS), B cells, immunoglobulin repertoire, disease modifying drugs (DMDs), immunoglobulin proteome, Epstein-Barr virus (EBV)